Literature DB >> 6548606

Esophageal, gastric, and intestinal candidiasis.

J S Trier, D J Bjorkman.   

Abstract

Gastrointestinal Candida infection is more prevalent than previously recognized. It is most often seen in patients with underlying impairment of the immune system but may also occur in apparently normal individuals. Esophageal involvement is most common, presenting with odynophagia, dysphagia, or bleeding. Gastric Candida infection may cause diffuse mucosal involvement or focal invasion of benign gastric ulcers. Intestinal candidiasis is uncommon and poorly characterized. The diagnosis is usually established by visualizing the characteristic yeast or mycelial forms in endoscopic brushings and biopsies. Oral nystatin is effective therapy in many patients, but other antifungal agents may be needed in extensive or persistent disease, especially in immunocompromised patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6548606

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  Growth of Candida albicans in a minimal synthetic medium without biotin.

Authors:  V Vidotto; A Pugliese; P Gioannini
Journal:  Mycopathologia       Date:  1987-10       Impact factor: 2.574

2.  State-of-the-art barium examination in opportunistic esophagitis.

Authors:  T N Vahey; D D Maglinte; S M Chernish
Journal:  Dig Dis Sci       Date:  1986-11       Impact factor: 3.199

3.  Factors affecting colonization and dissemination of Candida albicans from the gastrointestinal tract of mice.

Authors:  O Ekenna; R J Sherertz
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

4.  Esophageal candidiasis.

Authors:  Y Naito; T Yoshikawa; H Oyamada; K Tainaka; Y Morita; T Kogawa; S Sugino; M Kondo
Journal:  Gastroenterol Jpn       Date:  1988-08

5.  Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome.

Authors:  S Mahanty; R A Greenfield; W A Joyce; P W Kincade
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

6.  Candida-associated gastric ulcer relapsing in a different position with a different appearance.

Authors:  Kenji Sasaki
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

7.  Protection by Candida albicans of Staphylococcus aureus in the establishment of dual infection in mice.

Authors:  E Carlson; G Johnson
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

8.  Serial study of C-reactive protein during fungal esophagitis and enterocolitis.

Authors:  I Kostiala; A A Kostiala; E Elonen
Journal:  Infection       Date:  1987 Nov-Dec       Impact factor: 3.553

9.  Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis.

Authors:  M A Pfaller; J Rhine-Chalberg; S W Redding; J Smith; G Farinacci; A W Fothergill; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.